Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Readies Medtech And Pharma Sectors For Regulatory Life Outside The EU

Executive Summary

Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.

You may also be interested in...



UK Medicines And Medical Devices Bill Laid Before Parliament

UK health minister Baroness Blackwood will introduce the new UK Medicines and Medical Devices Bill before Parliament today, just before the House of Commons goes into recess. The government wants new legislation for devices and medicines in place before the end of the Brexit transition period.

Brexit And Medtech Regulation: Sorry To Spoil The Party But Experts Say There’s A Mess Here To Clear Up

31 January 2020 is an historic day as the UK formally leaves the EU. It is an emotional day, both for those wanting to see the UK depart and those who wanted the UK to remain. But the challenges are far from over. Medtech Insight reports on some reactions from key regulatory experts.

Progress And Pitfalls Ahead As UK Medtech Faces A Year Of Leaving The EU

As the UK enters the final week of its 47-year membership of the EU, UK medtech industry and commentators look ahead to the routes beyond Brexit for the UK, and a likely intense and often rocky 11 months of trade deal negotiations with EU and global partners. This article is part one of two.

Related Content

Topics

UsernamePublicRestriction

Register

MT126165

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel